Pulsenmore

Pulsenmore (NASDAQ, TASE: PLSM) is the world’s first at-home diagnostic ultrasound and telehealth platform for pregnancy well checks.

[Pulsenmore @pulsenmore]

Pulsenmore is a digital health company bringing connected prenatal care closer to home.

Pulsenmore ES has received FDA De Novo marketing authorization, enabling at-home ultrasound as part of clinician-led care.
Hashtags: #DigitalHealth #MedTech #PrenatalCare

[Pulsenmore @pulsenmore]

A lot has happened this quarter at Pulsenmore!
We're excited to share our latest newsletter, highlighting key milestones that continue to advance access to prenatal care and support the growing shift toward care at home.
https://t.co/PN4MFeJWeh

[Pulsenmore @pulsenmore]

Pregnancy care doesn't have to be confined to the clinic or hospital.
This week at HLTH we're excited to showcase how Pulsenmore is helping healthcare providers bring specialist pregnancy monitoring directly into patients' homes.
If you're attending stop by the Pulsenmore booth

[Pulsenmore @pulsenmore]

Enjoy the read: https://t.co/PFBqiu2ajT

[Pulsenmore @pulsenmore]

Published prospective study from UMCU in the demonstrated that pregnant women successfully performed 240 clinician-guided ultrasound examinations from home, with excellent usability, satisfaction, and successful assessment of fetal parameters.
Kudos Mireille N. Bekker and team!!!

[Pulsenmore @pulsenmore]

📩 Contact us to learn more about the growing body of research supporting home ultrasound.

[Pulsenmore @pulsenmore]

RCT led by Dr. Liat Mor et al. at Wolfson Medical Center, explored if access to home ultrasound could help provide reassurance during pregnancy. The results were:
Fewer emergency department visits
Significantly lower maternal anxiety scores and increased maternal attachment

[Pulsenmore @pulsenmore]

We want to thank everyone who stopped by the Pulsenmore booth, discussed integration pathways and shared their perspectives on the future of maternal-fetal care.
We're excited to explore new collaborations that can help advance prenatal care worldwide.

[Pulsenmore @pulsenmore]

Thank you to the MTAA and the organizers of the Women’s Health MedTech Summit.
Sam Ho, had a fantastic turnout while presenting Pulsenmore’s journey and sharing our experience achieving FDA DeNovo authorization for home ultrasound in the US.

[Pulsenmore @pulsenmore]

Join us to discover how home ultrasound is turning a vision into reality. Imagine a world where expectant mothers can connect from their living room, clinicians gain new visibility between visits, and hospitals extend their reach far beyond their walls. 📍 Hall 1 | Booth E40

[Pulsenmore @pulsenmore]

We’re excited to attend #AIUM2026 with our full U.S. commercial team.
At Pulsenmore, we work closely with providers to tailor prenatal care workflows that fit real clinical needs - from synchronous live tele-ultrasound consultations to asynchronous offline review models.

[Pulsenmore @pulsenmore]

Interested in learning more? Register here:
https://t.co/kys5Opl5an

[Pulsenmore @pulsenmore]

Are you planning to attend the Women’s Health MedTech Summit in Sydney tomorrow?

Sam Oh will be presenting Pulsenmore’s journey and sharing our experience achieving FDA De Novo approval for home ultrasound in the US — a truly extraordinary journey and milestone.

[Pulsenmore @pulsenmore]

Congratulations to Cetina and Carepoint for the amazing work they are doing to advance prenatal care in #Poland. 👏

In the image, you can see Dr. Kamila Węglarz onboarding one of her patients.

🔗 for more details :https://t.co/fywCt3Tyk6

[Pulsenmore @pulsenmore]

Join Mira Altmark Sofer, on May 14: “AI as an Equalizer: From Center to Periphery in Healthcare”
Mira will discuss how technologies like home ultrasound are helping make maternal healthcare more accessible, connected, and empowering for women everywhere.

[Pulsenmore @pulsenmore]

Thank you to everyone who visited our booth and showed such strong interest in our home ultrasound solution and its integration into clinical workflows.
We were also excited to have our newest US commercial team members join us: Sarah Moore, Chris Gannett &Julie Sorgen.
GO USA!!

[Pulsenmore @pulsenmore]

Pulsenmore is heading to ACOG’s Annual Clinical & Scientific Meeting in Washington, DC (May 1–3), and we couldn’t be more excited to be part of the conversation.
We’re looking forward to connecting with OB-GYNs, sharing insights, and showcasing our home ultrasound solution.

[Pulsenmore @pulsenmore]

Read the full newsletter here: https://t.co/fip4h39T0L

[Pulsenmore @pulsenmore]

Highlights from our latest newsletter
🔹 First commercial adoptions in the US
🔹 New clinical evidence
🔹 How Sheba is managing high-risk pregnancies during wartime
🔹 1 in 4 sonographer roles remain unfilled in the UK, can hybrid care help close the gap?
Link in the 1st comment

[Pulsenmore @pulsenmore]

A BBC article on how 1 in 4 sonographer roles in the UK are unfilled. Demand for ultrasound is rising, creating a bottleneck in diagnostic capacity. At Pulsenmore, we explore how at-home ultrasound could help extend clinical reach without adding burden.
https://t.co/hb36Xj5rN8

[Pulsenmore @pulsenmore]

We’re looking forward to connecting with a dedicated community of clinicians & researchers focused on improving perinatal care.
Inviting you see our latest poster: “Pulsenmore Self-Scan Proven Safe & Effective in HOLA (Home Ultrasound Assessment) USA-based Multicenter Study.”